Ultragenyx Pharmaceutical RARE Product — Sales Reserves
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept rare:SalesReserves.
The official record: Ultragenyx Pharmaceutical’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's product — sales reserves.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's product — sales reserves?
- Ultragenyx Pharmaceutical (RARE) reported product — sales reserves of $57M in Q4 2025.
- How has Ultragenyx Pharmaceutical's product — sales reserves changed year-over-year?
- Ultragenyx Pharmaceutical's product — sales reserves increased by 72.7% year-over-year, from $33M to $57M.
- What does product — sales reserves mean?
- This represents the cumulative balance of estimated liabilities set aside to cover potential future deductions from gross revenue, such as rebates, returns, and discounts. It reflects the company's accounting estimate of the difference between gross sales and net realized revenue. A stable or predictable reserve balance is essential for maintaining accurate financial reporting and revenue recognition.